Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study

作者
Michiel L. Bots,M K Palmer,S. Dogan,Yvonne Plantinga,J.S. Raichlen,Gregory W. Evans,Daniel H. O’Leary,Diederick E. Grobbee,John R. Crouse,METEOR Study Group
出处
期刊:Journal of Internal Medicine [Wiley]
卷期号:265 (6): 698-707 被引量:38
标识
DOI:10.1111/j.1365-2796.2009.02073.x
摘要

BACKGROUND: In several statin trials, vascular event rates for treatment groups begin to separate 1 year after commencement of treatment. For atherosclerosis progression, the temporal sequence of the effect has not been defined. We used data from the Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin (METEOR) trial to determine the earliest time point at which significant differences in atherosclerosis progression rates could be detected after initiation of statin therapy. METHODS: The METEOR trial was a double-blind, randomized placebo-controlled trial that studied the effect of LDL-C lowering with 40 mg rosuvastatin on the rate of change of carotid intima media thickness (CIMT) measured by B-mode ultrasound amongst 984 low risk subjects. Ultrasound assessments were made at baseline and every 6 months up to 2 years. RESULTS: Rosuvastatin treatment was associated with a 49% reduction in LDL-C-C, a 34% reduction in total cholesterol, an 8.0% increase in HDL-C and a 16% reduction in triglycerides (all P < 0.0001 compared with placebo). The difference in rate of mean maximum CIMT progression between the rosuvastatin and placebo groups (based on near and far wall measurements from both left and right common carotid and internal carotid segments and carotid bifurcation) was not statistically significant after 6 months (0.0023 mm year(-1) and 0.0106 mm year(-1), respectively P = 0.34). After 12 months, CIMT progression rates were significantly different between the groups: 0.0032 mm year(-1) and 0.0133 mm year(-1) in the rosuvastatin-treated and placebo-treated groups, respectively (P = 0.049). This divergence grew with further follow-up: -0.0009 mm year(-1) and 0.0131 mm year(-1) after 18 months (P < 0.001) and -0.0014 mm year(-1) and 0.0131 mm year(-1) after 24 months of treatment (P < 0.001). Results were stronger for the mean common CIMT progression (based on near and far wall measurements from both left and right common carotid segments). CONCLUSION: Aggressive LDL-C lowering seems to exert its beneficial effect on atherosclerosis progression during the first 12 months of treatment. This parallels the timing of event reduction seen in clinical trials and suggests that the efficacy of lipid lowering treatment on CIMT progression can be evaluated in trials with a duration of 1 year, given sufficient sample size, high precision of measurements and a treatment effect comparable to that seen in METEOR.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
乎乎完成签到,获得积分10
1秒前
一一完成签到,获得积分10
1秒前
万能图书馆的应助被杰杰小杰采纳,获得10
1秒前
善良梦竹完成签到 ,获得积分10
2秒前
碧蓝可乐完成签到,获得积分10
2秒前
HZH完成签到 ,获得积分10
2秒前
369ninja发布了新的文献求助10
3秒前
qdstisti完成签到,获得积分10
3秒前
再见了星空完成签到,获得积分0
3秒前
活泼红牛完成签到,获得积分10
4秒前
喜悦白玉完成签到,获得积分10
4秒前
小小鱼儿完成签到,获得积分10
4秒前
清爽的灵竹完成签到,获得积分10
4秒前
小J完成签到,获得积分10
4秒前
可爱可愁完成签到,获得积分10
5秒前
白枫完成签到 ,获得积分10
5秒前
5秒前
yuuu完成签到 ,获得积分10
5秒前
兔子爱吃胡萝卜完成签到,获得积分10
5秒前
chujiu完成签到 ,获得积分10
5秒前
6秒前
枕月听松完成签到,获得积分10
6秒前
6秒前
7秒前
笑嘻嘻完成签到,获得积分10
7秒前
冷酷的天宇完成签到,获得积分10
7秒前
weizhi完成签到,获得积分10
8秒前
今后的应助被晴天采纳,获得10
8秒前
无花果的应助被Crazy_Runner采纳,获得10
8秒前
舒心易烟完成签到,获得积分10
8秒前
jessie完成签到,获得积分10
9秒前
专业论文的应助被伍安采纳,获得10
10秒前
GLORIA的应助被伍安采纳,获得10
10秒前
10秒前
红鱼完成签到,获得积分10
10秒前
长乐发布了新的文献求助10
10秒前
斯文的捕完成签到 ,获得积分10
10秒前
Davey1220完成签到,获得积分10
11秒前
11秒前
开心恶天完成签到,获得积分10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180135
求助须知:如何正确求助?哪些是违规求助? 9570290
关于积分的说明 21809391
捐赠科研通 7776237
什么是DOI,文献DOI怎么找? 3433266
关于科研通互助平台的介绍 2557465
邀请新用户注册赠送积分活动 2479039